Total Payments
$6,580
2024 Payments
$1,986
Companies
31
Transactions
273
Medicare Patients
2,544
Medicare Billing
$337,547
Payment Breakdown by Category
Food & Beverage$6,396 (97.2%)
Education$183.42 (2.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,396 | 272 | 97.2% |
| Education | $183.42 | 1 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $680.44 | 39 | $0 (2024) |
| PFIZER INC. | $676.09 | 33 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $643.35 | 22 | $0 (2024) |
| Abbott Laboratories | $624.12 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $590.74 | 36 | $0 (2024) |
| Amgen Inc. | $353.93 | 13 | $0 (2024) |
| ABIOMED | $308.95 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $282.33 | 15 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $256.80 | 13 | $0 (2024) |
| ShockWave Medical, Inc | $222.94 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,986 | 91 | Boehringer Ingelheim Pharmaceuticals, Inc. ($331.04) |
| 2023 | $2,128 | 85 | Novartis Pharmaceuticals Corporation ($295.03) |
| 2022 | $1,226 | 52 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($257.91) |
| 2021 | $769.09 | 29 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($281.69) |
| 2020 | $138.13 | 7 | PFIZER INC. ($60.89) |
| 2019 | $331.49 | 9 | Abbott Laboratories ($183.42) |
All Payment Transactions
273 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Heart Failure | ||||||
| 12/16/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Heart Failure | ||||||
| 12/16/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Heart Failure | ||||||
| 12/10/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/05/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Cardiology | ||||||
| 12/04/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $222.94 | General |
| Category: Lithoplasty | ||||||
| 11/27/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: Heart Failure | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $31.08 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | ATRICURE, INC. | ATRICLIP LAA EXCLUSION SYSTEM (Device) | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/29/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Cardiology | ||||||
| 10/24/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $31.08 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Genetic Disease | ||||||
| 10/14/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Heart Failure | ||||||
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: DIABETES | ||||||
| 09/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: DIABETES | ||||||
| 09/25/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Genetic Disease | ||||||
| 09/17/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Not Applicable | ||||||
| 09/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $8.28 | General |
| Category: DIABETES | ||||||
| 09/05/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $47.40 | General |
| Category: Cardiology | ||||||
| 08/29/2024 | ATRICURE, INC. | ATRICLIP LAA EXCLUSION SYSTEM (Device) | Food and Beverage | In-kind items and services | $33.67 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: DIABETES | ||||||
| 08/22/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 08/20/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,876 | 3,404 | $709,994 | $256,659 |
| 2022 | 15 | 668 | 955 | $217,534 | $80,888 |
Total Patients
2,544
Total Services
4,359
Medicare Billing
$337,547
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 291 | 598 | $94,484 | $59,521 | 63.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 204 | 502 | $125,500 | $48,793 | 38.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 149 | 156 | $42,900 | $20,792 | 48.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 100 | 104 | $72,800 | $17,525 | 24.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 41 | 41 | $45,100 | $16,577 | 36.8% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 21 | 21 | $38,622 | $16,397 | 42.5% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 38 | 340 | $32,015 | $11,585 | 36.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 41 | 237 | $27,255 | $10,029 | 36.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 166 | 175 | $42,000 | $9,299 | 22.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 36 | 201 | $30,150 | $9,294 | 30.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 64 | 64 | $13,050 | $8,079 | 61.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 42 | 168 | $17,640 | $7,554 | 42.8% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 47 | 90 | $72,000 | $6,582 | 9.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 77 | 77 | $20,405 | $4,688 | 23.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 200 | 248 | $12,400 | $2,861 | 23.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 14 | $4,200 | $2,160 | 51.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 210 | 231 | $3,003 | $1,517 | 50.5% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 13 | 15 | $7,500 | $1,330 | 17.7% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 23 | 23 | $2,070 | $490.82 | 23.7% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 22 | 22 | $1,650 | $454.44 | 27.5% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 14 | 14 | $910.00 | $274.68 | 30.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 14 | 14 | $1,050 | $248.22 | 23.6% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 14 | 14 | $630.00 | $230.10 | 36.5% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 21 | 21 | $1,680 | $221.40 | 13.2% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 14 | 14 | $980.00 | $156.94 | 16.0% |
About Dr. Yu-Ming Ni, MD
Dr. Yu-Ming Ni, MD is a Internal Medicine healthcare provider based in Fountain Valley, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2016. The National Provider Identifier (NPI) number assigned to this provider is 1033565338.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yu-Ming Ni, MD has received a total of $6,580 in payments from pharmaceutical and medical device companies, with $1,986 received in 2024. These payments were reported across 273 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($6,396).
As a Medicare-enrolled provider, Ni has provided services to 2,544 Medicare beneficiaries, totaling 4,359 services with total Medicare billing of $337,547. Data is available for 2 years (2022–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Fountain Valley, CA
- Active Since 05/05/2016
- Last Updated 07/07/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1033565338
Products in Payments
- JARDIANCE (Drug) $707.11
- ELIQUIS (Drug) $663.96
- LifeVest (Device) $643.35
- LEQVIO (Drug) $431.35
- Impella (Device) $308.95
- CARDIOMEMS (Device) $280.74
- FARXIGA (Drug) $249.69
- Repatha (Biological) $228.93
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $222.94
- PRALUENT (Biological) $214.91
- ATRICLIP LAA EXCLUSION SYSTEM (Device) $200.49
- HeartMate 3 Left Ventricular Dev (Device) $183.42
- XARELTO (Drug) $169.94
- AMVUTTRA (Drug) $166.23
- MITRACLIP (Device) $159.96
- ENTRESTO (Drug) $159.39
- VYNDAQEL (Drug) $144.50
- VERQUVO (Drug) $130.08
- Arcalyst (Drug) $114.76
- Assure WCD (Device) $107.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fountain Valley
Truong-Sinh Leduc, M.d, M.D
Internal Medicine — Payments: $274,359
Internal Medicine $274,359
Rufina Pamela Mae Miel, Md, MD
Internal Medicine — Payments: $83,665
Internal Medicine $83,665
Dr. Janet Pan, M.d, M.D
Internal Medicine — Payments: $46,647
Internal Medicine $46,647
Pete Pow-Anpongkul
Internal Medicine — Payments: $26,930
Internal Medicine $26,930
Dr. Samarjit Singh, Md, MD
Internal Medicine — Payments: $25,901
Internal Medicine $25,901
Dr. Hoang Nguyen, M.d, M.D
Internal Medicine — Payments: $19,529
Internal Medicine $19,529